Research progress of cerebral hyperperfusion syndrome

Q4 Medicine

中国现代神经疾病杂志 Pub Date : 2017-12-25 DOI:10.3969/CJCNN.V17I12.1701

Guangquan Zhang, Shiyi Zhu, Zhi-yong Ji, Pei-quan Zhou, Shancai Xu, Huaizhang Shi

引用次数: 1

Abstract

Cerebral hyperperfusion syndrome (CHS) is a rare syndrome deriving from carotid endovascular treatment with a high mortality. CHS can be derived by carotid endarterectomy (CEA), carotid artery stenting (CAS) and intracranial artery stenting. This review aims to summarize the progress of clinical manifestations, risk factors, pathogenesis, diagnostic criteria, prevention and treatment for CHS in recent years. DOI: 10.3969/j.issn.1672-6731.2017.12.003

查看原文本刊更多论文

脑过度灌注综合征的研究进展

脑过度灌注综合征（CHS）是一种罕见的颈动脉血管内治疗综合征，死亡率很高。CHS可通过颈动脉内膜切除术（CEA）、颈动脉支架术（CAS）和颅内动脉支架术获得。本文就近年来CHS的临床表现、危险因素、发病机制、诊断标准、防治等方面的进展进行综述。DOI:10.3969/j.issn.1672-6731017.12.003

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊